Astec LifeSciences LimitedASTECNSE
Outcome of Board Meeting held on April 27, 2026
As filed · Astec LifeSciences Limited has informed the Exchange regarding Outcome of Board Meeting held on April 27, 2026.
EarningsNotablemateriality 73 out of 100
What happened
FactThe Board of Directors of ASTEC approved the audited financial results (standalone and consolidated) for the quarter and financial year ended 31st March, 2026, along with the cash flow statement and statement of assets and liabilities. The statutory auditors' reports on these results were noted, with an unmodified opinion. Additionally, the 32nd Annual General Meeting is scheduled for 31st July, 2026, at 4.00 p.m.
Why it matters
CapitSignal interpretationReported results are the point at which prior management commitments become checkable against audited or reviewed numbers.
Watch next
Fact- Margin trend against the prior period
- Cash from operations against reported profit
- Whether prior guidance is reaffirmed
Evidence
How CapitSignal classified this
- Reasoning:
- RESULTS base 68; +5 quantified amount; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 75%